RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced-intensity conditioning in a large cohort of consecutive high-risk patients
2012-01-01 Rambaldi A; Andrea B; Fanin R; Ciceri F; Bonifazi F; Falda M; Lambertenghi-Deliliers G; Benedetti F; Bruno B; Corradini P; Alessandrino P; Iacopino P; Arcese W; Scime R; Raimondi R; Sica S; Todisco E; Lamparelli T; Oneto R; Lombardini L; Pollichieni S; Algarotti A; Carobbio A; Sacchi N; Bosi A
Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors
2010-01-01 Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; Georg N. Franke; Ginna G. Laport; Thomas Chauncey; Edward Agura; Michael T. Maris; James Wade; Michael A. Pulsipher; Richard T Maziarz; Firoozeh Sahebi; Peter McSweeney; Benedetto Bruno; Lars indelov; V; Andrew M. Yeager; Andrew Rezvani; Dietger W Niederwieser; Karl G. Blume; Rainer F. Storb; and David G. Maloney
Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) after Non-Myeloablative Conditioning in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).
2007-01-01 Andrew R. Rezvani; L. Norasetthada; T. Gooley; Mohamed Sorror; Stephen J. Forman; Edward Agura; T. Chauncey; Richard T. Maziarz; Michael Maris; J. Shizuru; B. Bruno; James C. Wade; T. Lange; Andrew Yeager; Brenda M. Sandmaier; Rainer F. Storb; and David G. Maloney
Prognostic factors and outcome of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with multiple myeloma relapsed after autografting and rescued with new drugs
2011-01-01 Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P
Prognostic Relevance of "Early-Onset" Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.
2004-01-01 Marco Mielcarek; Lauri Burroughs; Wendy Leisenring; Paul Martin; Razvan Diaconezcu; Brenda Sandmaier; David Maloney; Thomas Chauncey; Michael Maris; Judith Shizuru; Karl Blume; Ute Hegenbart; Dietger Niederwieser; Stephen Forman; Benedetto Bruno; Ann Woolfrey; and Rainer Storb
Prospective molecular monitoring of minimal residual disease after nonmyeloablative allografting in newly diagnosed multiple myeloma
2014-01-01 Benedetto Bruno; Simone Ferrero; Daniela Drandi; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Daniela Barbero; Luigia Monitillo; Federica Ferrando; Luisa Giaccone; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè; Marco Ladetto
Qualitative and Quantitative Molecular Follow up of Minimal Residual Disease after Non Myeloablative Allografting for Multiple Myeloma.
2004-01-01 B. Bruno; M. Ladetto; M. Astolfi; L. Veneziano; L. Cimolin; E. Galletto; G. Pagliano; M. Rotta; N. Mordini; L. Giaccone; P. Omedè; S. Battaglio; R. Storb; and M. Boccadoro
REAL TIME PCR IN MULTIPLE MYELOMA: QUANTITATIVE ANALYSIS OF TUMOR CONTAMINATION OF STEM CELL HARVESTS
2001-01-01 Ladetto M; Omedè P; Sametti S; Donovan JW; Drandi D; Giaccone L; Volpato F; Astolfi M; Giaretta F; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M
REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAK BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTILY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM).
2000-01-01 Ladetto M; Omedè P; Sametti S; Donovan JW; Astolfi M; Giaccone L; Giaretta F; Volpato F; Bringhen S; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M.
REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAL BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTLY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM)
1996-01-01 LADETTO M; SAMETTI POS; DONOVAN JW; ASTOLFI M; GIACCONE L; GIARETTA F; VOPATA F; BRINGHEN S; PALUMBO A; BRUNO B; PILERI A; GRIBBEN JG; BOCCADORO M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Outcome of patients activating an unrelated donor search: the impact of transplant with reduced-intensity conditioning in a large cohort of consecutive high-risk patients | 2012 | Rambaldi A; Andrea B; Fanin R; Ciceri F; Bonifazi F; Falda M; Lambertenghi-Deliliers G; Benedetti F; Bruno B; Corradini P; Alessandrino P; Iacopino P; Arcese W; Scime R; Raimondi R; Sica S; Todisco E; Lamparelli T; Oneto R; Lombardini L; Pollichieni S; Algarotti A; Carobbio A; Sacchi N; Bosi A | |
| Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors | 2010 | Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; Georg N. Franke; Ginna G. Laport; Thomas Chauncey; Edward Agura; Michael T. Maris; James Wade; Michael A. Pulsipher; Richard T Maziarz; Firoozeh Sahebi; Peter McSweeney; Benedetto Bruno; Lars indelov; V; Andrew M. Yeager; Andrew Rezvani; Dietger W Niederwieser; Karl G. Blume; Rainer F. Storb; and David G. Maloney | |
| Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) after Non-Myeloablative Conditioning in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL). | 2007 | Andrew R. Rezvani; L. Norasetthada; T. Gooley; Mohamed Sorror; Stephen J. Forman; Edward Agura; T. Chauncey; Richard T. Maziarz; Michael Maris; J. Shizuru; B. Bruno; James C. Wade; T. Lange; Andrew Yeager; Brenda M. Sandmaier; Rainer F. Storb; and David G. Maloney | |
| Prognostic factors and outcome of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with multiple myeloma relapsed after autografting and rescued with new drugs | 2011 | Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P | |
| Prognostic Relevance of "Early-Onset" Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation. | 2004 | Marco Mielcarek; Lauri Burroughs; Wendy Leisenring; Paul Martin; Razvan Diaconezcu; Brenda Sandmaier; David Maloney; Thomas Chauncey; Michael Maris; Judith Shizuru; Karl Blume; Ute Hegenbart; Dietger Niederwieser; Stephen Forman; Benedetto Bruno; Ann Woolfrey; and Rainer Storb | |
| Prospective molecular monitoring of minimal residual disease after nonmyeloablative allografting in newly diagnosed multiple myeloma | 2014 | Benedetto Bruno; Simone Ferrero; Daniela Drandi; Moreno Festuccia; Francesca Patriarca; Nicola Mordini; Silvia Cena; Daniela Barbero; Luigia Monitillo; Federica Ferrando; Luisa Giaccone; Renato Fanin; Roberto Passera; Antonio Palumbo; Mario Boccadoro; Paola Omedè; Marco Ladetto | |
| Qualitative and Quantitative Molecular Follow up of Minimal Residual Disease after Non Myeloablative Allografting for Multiple Myeloma. | 2004 | B. Bruno; M. Ladetto; M. Astolfi; L. Veneziano; L. Cimolin; E. Galletto; G. Pagliano; M. Rotta; N. Mordini; L. Giaccone; P. Omedè; S. Battaglio; R. Storb; and M. Boccadoro | |
| REAL TIME PCR IN MULTIPLE MYELOMA: QUANTITATIVE ANALYSIS OF TUMOR CONTAMINATION OF STEM CELL HARVESTS | 2001 | Ladetto M; Omedè P; Sametti S; Donovan JW; Drandi D; Giaccone L; Volpato F; Astolfi M; Giaretta F; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M | |
| REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAK BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTILY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM). | 2000 | Ladetto M; Omedè P; Sametti S; Donovan JW; Astolfi M; Giaccone L; Giaretta F; Volpato F; Bringhen S; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M. | |
| REAL TIME QUANTITATIVE PCR SHOWS THAT PERIPHERAL BLOOD STEM CELL (PBPC) HARVESTS ARE SIGNIFICANTLY LESS CONTAMINATED THAN BONE MARROW (BM) IN MULTIPLE MYELOMA PATIENTS (MM) | 1996 | LADETTO M; SAMETTI POS; DONOVAN JW; ASTOLFI M; GIACCONE L; GIARETTA F; VOPATA F; BRINGHEN S; PALUMBO A; BRUNO B; PILERI A; GRIBBEN JG; BOCCADORO M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 186
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 168
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 11
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 5
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 1
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 1
Data di pubblicazione
- In corso di stampa 5
- 2010 - 2019 57
- 2000 - 2009 110
- 1994 - 1999 14
Editore
- WORLD SCIENTIFIC 1
Rivista
- BLOOD 86
- BONE MARROW TRANSPLANTATION 41
- HAEMATOLOGICA 35
- BIOLOGY OF BLOOD AND MARROW TRANS... 8
- ANNALS OF ONCOLOGY 2
- JOURNAL OF CLINICAL ONCOLOGY 2
- CURRENT OPINION IN HEMATOLOGY 1
- HAEMATOLOGICA REPORTS 1
- HLA 1
- INTERNATIONAL JOURNAL OF MOLECULA... 1
Lingua
- eng 184
- Inglese 1
- ita 1
Accesso al fulltext
- no fulltext 169
- open 16
- reserved 1